On Friday September 26, President Emomali Rahmon of Tajikistan inaugurated a newly constructed Pediatric Tuberculosis Hospital in Vahdat as part of his official visit to the city, according to the Tajik president’s official website.  The facility operates under the National Center for Tuberculosis, Pulmonology, and Thoracic Surgery and is expected to significantly improve the country’s pediatric TB treatment infrastructure.

The hospital was built with support from the Tajik government and financial backing from the German Development Bank (KfW).  The total project cost amounted to €2.595 million.  Construction began in 2023 and was completed in September 2025.

Covering an area of approximately 15,400 square meters, the hospital building itself spans 1,554.8 square meters.  The new two-story facility is designed to accommodate 50 patients and includes dedicated wards for children with active TB, recurrent infections, drug-resistant TB, and a pediatric surgical unit.

During his visit, President Rahmon inspected the hospital’s modern facilities and reiterated that child healthcare and public health remain top priorities for the government.

Part of a broader national TB strategy

The opening of the pediatric TB hospital is the latest step in Tajikistan’s long-term fight against tuberculosis, which has seen sustained investment and international cooperation over the years.

Back in 2006, with the support of President Rahmon and financial assistance from the Tajik government and the German Development Bank, reconstruction began on the Republican Clinical Tuberculosis Hospital. That facility officially reopened in 2011 and was transformed into the National Center for Tuberculosis in 2013. Today, the center operates 14 departments with a total capacity of 420 beds.

In 2024, Tajikistan introduced a new diagnostic method for tuberculosis in children. The innovative one-step approach allows for TB detection through stool analysis — eliminating the need for induced sputum collection, which is particularly difficult in children under five. According to the Republican Center for TB Control, this method has proven just as reliable as sputum testing, without yielding a single false negative.

Experts highlighted the innovation as a breakthrough, making pediatric TB diagnosis more accessible, accurate, and less invasive — a critical improvement in the country’s broader health strategy.